Table 1.

Selected clinical studies of beta-blocker effects in cancer patients

Tumor site	Study name	Total patients (patients on beta-blockers)
Prostate	Grytli et al. (2013)	3561 (1115)
Lung	Wang et al. (2013)	722 (155)
Ovarian	Diaz et al. (2012)	248 (23)
Breast	Melhem-Bertrandt et al. (2011)	1413 (102)
Breast	Barron et al. (2011)	5801 (propranolol:70, atenolol: 525)
Melanoma	Lemeshow et al. (2011)	4179 (372)
Breast	Powe et al. (2010)	466 (43)
Recurrent Ovarian Cancer	Heitz et al. (2013)	381 (38)